Axon Enterprise, Inc.
AXONLast close · Oct 16, 2026390.29−26.90 (−6.45%)
Market cap$31.7B
6 firms' latest targets, last 90 days: median $681.50 ($600.00–$732.00), 75% above the last close.
Price and published targets
Each firm's latest target
| Date | Firm | Target | Change | Vs price now |
|---|---|---|---|---|
| 2026-10-15 | Raymond James | $675.00 | — | +73% |
| 2026-09-03 | Argus Research | $600.00 | — | +54% |
| 2026-08-06 | Morgan Stanley | $640.00 | ▲ 7% | +64% |
| 2026-08-06 | Goldman Sachs | $715.00 | ▲ 34% | +83% |
| 2026-08-06 | Piper Sandler | $732.00 | ▲ 1% | +88% |
| 2026-08-06 | Barclays | $688.00 | ▲ 32% | +76% |
Consensus estimates
| FY | Revenue | YoY | EPS | YoY | Revenue range | EPS range | Analysts |
|---|---|---|---|---|---|---|---|
| 2021reported | $863.4M | +27% | -$0.91 | — | est. $848.8M+2% | est. $2.05 | 4 |
| 2022reported | $1.2B | +38% | $2.03 | — | est. $1.2B+3% | est. $2.00 | 3 |
| 2023reported | $1.6B | +31% | $2.31 | +14% | est. $1.6B+1% | est. $3.86 | 9 |
| 2024reported | $2.1B | +33% | $4.80 | +108% | est. $2.1B+0% | est. $5.14 | 11 |
| 2025reported | $2.8B | +33% | $1.51 | -69% | est. $2.7B+2% | est. $6.31 | 11 |
| 2026 | $3.7B | +33% | $7.69 | +22% | $3.5B–$3.7B | $6.17–$8.59 | 15 |
| 2027 | $4.8B | +30% | $10.60 | +38% | $4.4B–$5.0B | $8.56–$12.27 | 15 |
| 2028 | $6.2B | +28% | $13.79 | +30% | $5.8B–$6.8B | $13.12–$14.72 | 13 |
Targets, grades and estimates are quoted from third parties (via Financial Modeling Prep) and are theirs, not ours; each target links to the report it was published in. A firm counts once, at its latest target or grade.